In regards to CR-8358, the company recently announced complete readiness to provide clients with the necessary data, electronic medical record integration capability,and custom report generation...
Steubenville, OH (PRWEB) January 21, 2014
CR-8358 describes the new demands of additional data reporting requirements for the hospice industry. As we inch closer to the mandatory reporting effective date of April 1, 2014, Hospices nationwide are scrambling to identify pharmacy benefit managers (PBMs) capable of helping them handle this unexpected and difficult change in reporting requirements.
Preparing for this difficult period of transition has been less of a concern for the clients of Delta Care Rx. In regards to CR-8358, the company recently announced complete readiness to provide clients of theirs with the necessary data, electronic medical record integration capability, and custom report generation needed to support the provision of additional data reporting.
The privately held, pharmacist owned and operated, hospice specific, nationwide pharmacy benefit management (PBM) company has built a rapidly expanding book of business by staying true to the core values that brought the company to life years ago. REAL business transparency, pass-through and fully auditable medication purchasing agreements, innovative technology unique to the company, extreme customer service, and decades of hospice industry experience on the part of ownership, management, and staff has put the Ohio based company at the top of the list when it comes to competent and up-to-date Hospice Pharmacy Benefit Management services.
More information about the company’s readiness to support current and prospective Hospice clients is available at http://www.DeltaCareRx.com.
"It's not immoral nor unethical to think about the cost of therapy."